Collagen Solutions plc (COS.L) (COS) Share Price, News & Analysis

Company Overview

Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 6.63 to 6.63
• 52-Week Range: N/A
• Volume: 15,000 shs
• Average Volume: 298,181 shs
• Market Capitalization: £30.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COS Stock Analysis - Frequently Asked Questions

How were Collagen Solutions plc (COS.L)'s earnings last quarter?

Collagen Solutions plc (COS.L) (LON:COS) released its earnings results on Friday, July, 31st. The company reported ($0.76) earnings per share for the quarter.

How do I buy shares of Collagen Solutions plc (COS.L)?

Shares of COS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Collagen Solutions plc (COS.L) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Collagen Solutions plc (COS.L) investors own include ReNeuron Group (RENE), Sareum (SAR), Oxford Biomedica (OXB), ValiRx (VAL), Active Energy Group (AEG), Meta Platforms (META) and Norcros (NXR).

Company Calendar

• Last Earnings: 7/31/2020
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Insurance
• Current Symbol: LON:COS
• CUSIP: N/A
• CIK: N/A
• Web: www.collagensolutions.com
• Phone: +44-141-6489100
• Fax: N/A
• Employees: 3,350
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 7.49
• Current Ratio: 1.24
• Quick Ratio: 1.10

Sales & Book Value

• Annual Sales: £4.01 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 13.25
• Book Value: GBX 4 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 467,830,016
• Free Float: N/A
• Market Cap: £30.99 million
• Optionable: Not Optionable
• Beta: N/A